Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRD101 vs sodium hyaluronate for periarthritis of shoulder
CTR20170276Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Apr 2017
- Countries
- 1
01
Overview
A Phase 3 trial of hyaluronic acid in Periarthritis humeroscapularis, sponsored by Chugai Pharmaceutical Co., Ltd.. Started Apr 2017; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
Periarthritis humeroscapularis
Beyond the preview
Go deeper on CTR20170276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170276.